Feb 28, 2025 / 01:30PM GMT
Christopher Gibson - Recursion Pharmaceuticals Inc - Chief Executive Officer, Director
Welcome everybody to Recursion's Learning Skull. I'm Chris Gibson, co-founder and CEO, and I'm excited to take you through, recursions 2024, 2025, and, the time ahead. So with that, we'll jump into the slides, and I want to just set the stage, first of all, to share a little bit about the moment in time that we're in right now. Recursion is leading this field of tech bio. We're at the frontier of this exciting opportunity to decode biology, to change the way that drugs are discovered and developed. And I think what we're seeing in 2024 recursion are leading indicators of what this inevitable future may look like. And what we're going to see moving into 2025 now is a cascade of proof points that are going to make it more and more obvious to everyone about what the future of the biopharma industry looks like. Now, to talk a little bit about how we've gotten to this place in 2024, I want to dive into some of the the year in review, so to speak. And I want to kick that off by talking about our clinical data readouts. Last
Q4 2024 Recursion Pharmaceuticals Inc Earnings Call Transcript
Feb 28, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers